MicroRNA-195a-3p inhibits angiogenesis by targeting Mmp2 in murine mesenchymal stem cells

Molecular Reproduction and Development

Volumn 83, Issue 5, 2016, Pages 413-423

  Gao, Fan ^a   Sun, Meng ^b   Gong, Yumei ^b   Wang, Haiyan ^a   Wang, Yusheng ^a   Hou, Huiyuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GELATINASE A; MICRORNA; MICRORNA 195A 3P; PIGMENT EPITHELIUM DERIVED FACTOR; UNCLASSIFIED DRUG; EYE PROTEIN; MIRN195 MICRORNA, MOUSE; MMP2 PROTEIN, MOUSE; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPOXIA; CELL PROLIFERATION; DRUG TARGETING; ECTOPIC EXPRESSION; IN VITRO STUDY; LASER-INDUCED CHOROIDAL NEOVASCULARIZATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BONE MARROW CELL; DISEASE MODEL; FEMALE; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SUBRETINAL NEOVASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BONE MARROW CELLS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEMALE; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; NERVE GROWTH FACTORS; SERPINS;

EID: 84962721417     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.22638     Document Type: Article

References (61)

1. Abdollahi A, Folkman J. 2010. Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Updat 13:16-28.
2. AM Abu El-Asrar, S Struyf, H Verbeke, J Van Damme, K. Geboes, Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmol 89 2011; 222-228.
3. Afzal A, Shaw LC, Ljubimov AV, Boulton ME, Segal MS, Grant MB. 2007. Retinal and choroidal microangiopathies: Therapeutic opportunities. Microvasc Res 74:131-144.
4. Alcantara MB, Dass CR. 2013. Regulation of MT1-MMP and MMP-2 by the serpin PEDF: A promising new target for metastatic cancer. Cell Physiol Biochem 31:487-494.
5. Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT, Calin GA, Santos SG, Barbosa MA. 2016. MiR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget 7:7-22.
6. Amrite A, Pugazhenthi V, Cheruvu N, Kompella U. 2010. Delivery of celecoxib for treating diseases of the eye: Influence of pigment and diabetes. Expert Opin Drug Deliv 7:631-645.
7. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
8. Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN. 2006. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 142:1-9.
9. Bellafiore M, Battaglia G, Bianco A, Farina F, Palma A, Paoli A. 2013. The involvement of MMP-2 and MMP-9 in heart exercise-related angiogenesis. J Transl Med 11:283.
10. Bergers G, Hanahan D. 2008. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8:592-603.
11. Berglin L, Sarman S, van der Ploeg I, Steen B, Ming Y, Itohara S, Seregard S, Kvanta A. 2003. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 44:403-408.
12. Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA. 2006. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82:99-110.
13. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, Group AS. 2006. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444.
14. Cai C, Chen QB, Han ZD, Zhang YQ, He HC, Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, Qin GQ, Liang YX, Dai QS, Jiang FN, Wu SL, Zeng GH, Zhong WD, Wu CL. 2015. MiR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Clin Cancer Res 21:4922-4934.
15. Cai J, Yin G, Lin B, Wang X, Liu X, Chen X, Yan D, Shan G, Qu J, Wu S. 2014. Roles of NFkappaB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization. J Neuroinflammation 11:88.
16. Chan NS, Teo K, Cheung CM. 2016. Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia. Eye Contact Lens 42:48-55.
17. Chen K, Rajewsky N. 2007. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8:93-103.
18. Cho YR, Kim JH, Kim JK, Ahn EK, Ko HJ, In JK, Lee SJ, Bae GU, Kim YK, Oh JS, Seo DW. 2014. Broussonetia kazinoki modulates the expression of VEGFR-2 and MMP-2 through the inhibition of ERK, Akt and p70S6Kdependent signaling pathways: Its implication in endothelial cell proliferation, migration and tubular formation. Oncol Rep 32:1531-1536.
19. Du X, Lin LI, Zhang L, Jiang J. 2015. MicroRNA-195 inhibits the proliferation, migration and invasion of cervical cancer cells via the inhibition of CCND2 and MYB expression. Oncol Lett 10:2639-2643.
20. Esfahanian N, Shakiba Y, Nikbin B, Soraya H, Maleki-Dizaji N, Ghazi-Khansari M, Garjani A. 2012. Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells. Mol Med Rep 5:1068-1074.
21. Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, Dalton HJ, Rodriguez-Aguayo C, Fernandez-de Thomas RJ, Aslan B, Del CMP, Velazquez-Torres G, Previs RA, Pradeep S, Kahraman N, Wang H, Kanlikilicer P, Ozpolat B, Calin G, Sood AK, Lopez-Berestein G. 2015. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clin Cancer Res 21:2127-2137.
22. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27:91-105.
23. Grippo PJ, Fitchev PS, Bentrem DJ, Melstrom LG, Dangi-Garimella S, Krantz SB, Heiferman MJ, Chung C, Adrian K, Cornwell ML, Flesche JB, Rao SM, Talamonti MS, Munshi HG, Crawford SE. 2012. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut 61:1454-1464.
24. Grossniklaus HE, Green WR. 2004. Choroidal neovascularization. Am J Ophthalmol 137:496-503.
25. Hassel D, Cheng P, White MP, Ivey KN, Kroll J, Augustin HG, Katus HA, Stainier DY, Srivastava D. 2012. MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. Circ Res 111:1421-1433.
26. Hou HY, Liang HL, Wang YS. 2011. Bone marrow-derived cells in neovascular age-related macular degeneration: Contribution and potential application. Ophthalmic Res 45:1-4.
27. Hou HY, Liang HL, Wang YS, Zhang ZX, Wang BR, Shi YY, Dong X, Cai Y. 2010. A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions. Mol Ther 18:1837-1845.
28. Hou HY, Wang YS, Xu JF, Wang BR. 2008. Nicotine promotes contribution of bone marrow-derived cells to experimental choroidal neovascularization in mice. Exp Eye Res 86:983-990.
29. Hou HY, Wang YS, Xu JF, Wang YC, Liu JP. 2006. The dynamic conduct of bone marrow-derived cells in the choroidal neovascularization microenvironment. Curr Eye Res 31:1051-1061.
30. Huang H, Shen J, Vinores SA. 2011. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS ONE 6:e21411.
31. Jain M, Zhang L, Boufraqech M, Liu-Chittenden Y, Bussey K, Demeure MJ, Wu X, Su L, Pacak K, Stratakis CA, Kebebew E. 2014. ZNF367 inhibits cancer progression and is targeted by miR-195. PLoS ONE 9:e101423.
32. Kim VN. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385.
33. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat Genet 37:495-500.
34. Lai Y, Zhang X, Zhang Z, Shu Y, Luo X, Yang Y, Wang X, Yang G, Li L, Feng Y. 2013. The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells. Int J Oncol 42:776-784.
35. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T, Werb Z, Baker A, Libert C, Krell HW, Foidart JM, Noel A, Rakic JM. 2003. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 17:2290-2292.
36. Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA. 2002a. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 43:2428-2434.
37. Mori K, Gehlbach P, Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA. 2002b. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43:1994-2000.
38. Nguyen M, Arkell J, Jackson CJ. 2001. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33:960-970.
39. Notari L, Miller A, Martinez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP. 2005. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: Implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 46:2736-2747.
40. Ohno-Matsui K, Uetama T, Yoshida T, Hayano M, Itoh T, Morita I, Mochizuki M. 2003. Reduced retinal angiogenesis in MMP-2-deficient mice. Invest Ophthalmol Vis Sci 44:5370-5375.
41. Okada M, Kim HW, Matsu-Ura K, Wang YG, Xu M, Ashraf M. 2016. Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase. Stem Cells 34:148-159.
42. Park SL, Cho TM, Won SY, Song JH, Noh DH, Kim WJ, Moon SK. 2015. MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression. Oncol Rep 34:1605-1612.
43. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, Haas TL. 2002. Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 283:H1430-H1438.
44. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS. 2006. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431.
45. Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, Rakic JM, Noel A, Martial JA, Struman I. 2011. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS ONE 6:e16979.
46. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, Kirita T, Kuniyasu H. 2012. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 107:700-706.
47. Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, Campochiaro PA. 2008. MicroRNAs regulate ocular neovascularization. Mol Ther 16:1208-1216.
48. Singh R, Yadav V, Kumar S, Saini N. 2015. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci Rep 5:17454.
49. Small EM, Olson EN. 2011. Pervasive roles of microRNAs in cardiovascular biology. Nature 469:336-342.
50. Stetler-Stevenson WG. 1999. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 103:1237-1241.
51. Tong JP, Yao YF. 2006. Contribution of VEGF and PEDF to choroidal angiogenesis: A need for balanced expressions. Clin Biochem 39:267-276.
52. Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79:581-588.
53. Wang R, Zhao N, Li S, Fang JH, Chen MX, Yang J, Jia WH, Yuan Y, Zhuang SM. 2013. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Hepatology 58:642-653.
54. Wang S, Olson EN. 2009. AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 19:205-211.
55. Wilcock DM, Morgan D, Gordon MN, Taylor TL, Ridnour LA, Wink DA, Colton CA. 2011. Activation of matrix metalloproteinases following anti-Abeta immunotherapy; implications for microhemorrhage occurrence. J Neuroinflammation 8:115.
56. Xu H, Hu YW, Zhao JY, Hu XM, Li SF, Wang YC, Gao JJ, Sha YH, Kang CM, Lin L, Huang C, Zhao JJ, Zheng L, Wang Q. 2015. MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma. Oncol Rep 34:175-182.
57. Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, Lai L, Jiang BH. 2012. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40:761-774.
58. Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M. 2002. Long-term visual prognosis of choroidal neovascularization in high myopia: A comparison between age groups. Ophthalmology 109:712-719.
59. Zachary I. 2005. Neuroprotective role of vascular endothelial growth factor: Signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14:207-221.
60. Zhang ZX, Wang YS, Shi YY, Hou HY, Zhang C, Cai Y, Dou GR, Yao LB, Li FY. 2011. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model. Curr Eye Res 36:838-849.
61. Zhou Q, Anderson C, Zhang H, Li X, Inglis F, Jayagopal A, Wang S. 2014. Repression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24. Mol Ther 22:378-389.